Marc de Garidel, CinCor Pharma CEO (Eric Piermont/AFP via Getty Images)

How the price of As­traZeneca's buy­out of Cin­Cor fell by $1.4B

Cin­Cor scored a $1.8 bil­lion buy­out deal with As­traZeneca ear­li­er this month, but ac­cord­ing to re­cent­ly re­leased doc­u­ments, it al­most walked away from the deal …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.